Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Male genital desensitizing products

This article was originally published in The Tan Sheet

Executive Summary

FDA headquarters issues compliance bulletin for OTC male genital desensitizing products on May 18 to alert the field to a final monograph that goes into effect on June 19. FDA notes that only two ingredients -- benzocaine 3% to 7.5% in a water soluble base and lidocaine 10 mg metered spray -- were listed in the June 19, 1992 male genital desensitizing final monograph. The bulletin lists a group of products identified as making genital desensitizing claims, including Commerce Drug's Detane, Schmid Labs' Maintain Desensitizing Lubricant for Men, and Pound International's Stud 100 Spray for Men.

You may also be interested in...

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts